satavaptan has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, L; Li, Q; Liu, Z; Zhang, G; Zhang, M; Zhang, X; Zhou, X; Zhu, L | 1 |
| Iwao, H; Izumi, Y; Miura, K | 1 |
| Krieg, SM; Plesnila, N; Sonanini, S; Trabold, R | 1 |
| Buchholz, B; Donauer, J; Dworniczak, B; Eckardt, KU; Gerke, P; Geyer, M; Gloy, J; Kumar, R; Neumann, HP; Pennekamp, P; Puetz, M; Romaker, D; Rumberger, B; Teschner, S; Walz, G | 1 |
| Buechert, M; Hadjidemetriou, S; Hennig, J; Reichardt, W; von Elverfeldt, D | 2 |
| Ahrabi, AK; Caron, N; Devuyst, O; Horie, S; Nielsen, S; Raufaste, D; Serradeil-Le Gal, C; Terryn, S; Valenti, G; Verbavatz, JM | 1 |
| Abassi, ZA; Abu-Saleh, N; Azzam, ZS; Bishara, B; Hoffman, A; Karram, T; Nitecki, S; Rubinstein, I; Shiekh, H; Winaver, J | 1 |
| Barbier, A; Elena, PP; Lacheretz, F; Le Fur, G; Maffrand, JP; Serradeil-Le Gal, C | 1 |
1 review(s) available for satavaptan and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling | 2014 |
8 other study(ies) available for satavaptan and Disease Models, Animal
| Article | Year |
|---|---|
Participation of Antidiuretic Hormone (ADH) in Asthma Exacerbations Induced by Psychological Stress via PKA/PKC Signal Pathway in Airway-Related Vagal Preganglionic Neurons (AVPNs).
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Asthma; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Cytokines; Disease Models, Animal; Eosinophils; Female; Mice; Mice, Inbred BALB C; Morpholines; Neurons; Ovalbumin; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Receptors, Vasopressin; Signal Transduction; Spiro Compounds; Stress, Psychological; Vasopressins | 2017 |
Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Brain Edema; Brain Injuries; Disease Models, Animal; Indoles; Male; Mice; Mice, Inbred C57BL; Morpholines; Pyrrolidines; Receptors, Vasopressin; Spiro Compounds | 2015 |
Increased expression of secreted frizzled-related protein 4 in polycystic kidneys.
Topics: Animals; Cells, Cultured; Cyst Fluid; Disease Models, Animal; Humans; Kidney; Mice; Morpholines; Nephrons; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Proto-Oncogene Proteins; Signal Transduction; Spiro Compounds; Transcription Factors; TRPP Cation Channels; Wnt Proteins; Xenopus; Zebrafish | 2009 |
Analysis of MR images of mice in preclinical treatment monitoring of polycystic kidney disease.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Mice; Morpholines; Polycystic Kidney Diseases; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Spiro Compounds; Treatment Outcome | 2009 |
Volumetric analysis of MRI data monitoring the treatment of polycystic kidney disease in a mouse model.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Immunosuppressive Agents; Magnetic Resonance Imaging; Mice; Morpholines; Organ Size; Polycystic Kidney, Autosomal Dominant; Reproducibility of Results; Sirolimus; Spiro Compounds; Treatment Outcome | 2011 |
PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Calcium; Cell Polarity; Disease Models, Animal; Diuresis; Female; Haplotypes; Inappropriate ADH Syndrome; Kidney; Kidney Concentrating Ability; Kidney Tubules, Collecting; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Morpholines; Osmolar Concentration; Phosphorylation; Polycystic Kidney, Autosomal Dominant; Receptors, Vasopressin; Reverse Transcriptase Polymerase Chain Reaction; rhoA GTP-Binding Protein; Spiro Compounds; TRPP Cation Channels; Water-Electrolyte Balance | 2007 |
Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Body Weight; Cardiomegaly; Disease Models, Animal; Diuresis; Drug Administration Schedule; Heart Failure; Indoles; Kidney Function Tests; Male; Morpholines; Organ Size; Osmolar Concentration; Pyrrolidines; Rats; Rats, Sprague-Dawley; Sodium; Spiro Compounds; Vasoconstriction | 2008 |
Effect of SR121463, a selective non-peptide vasopressin V2 receptor antagonist, in a rabbit model of ocular hypertension.
Topics: Administration, Oral; Administration, Topical; Animals; Antidiuretic Hormone Receptor Antagonists; Cell Membrane; Clonidine; Disease Models, Animal; Injections, Intravenous; Intraocular Pressure; Kidney; Male; Morpholines; Ocular Hypertension; Rabbits; Receptors, Vasopressin; Safety; Spiro Compounds; Timolol | 2000 |